Artificial Intelligence in the Detection, Characterization, and Management of Renal Masses: A Narrative Review
Authors:
- Hasan F. BualiHBHasan F. Buali
- Tarek AbushloaTATarek Abushloa
- Abdulaziz Al ShaibaniASAbdulaziz Al Shaibani
- Ahmed BastawisyABAhmed Bastawisy
- Umar S. FarouqiUFUmar S. Farouqi
- Mohamed RafieMRMohamed Rafie
- Tarek Abushloa Sr.TSTarek Abushloa Sr.
- Umar S. Farouqi Sr.USUmar S. Farouqi Sr.
Open Access
- 9 July 2026
- journal article
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Abstract
Kidney tumors are being found more often today because CT and MRI scans are widely used and kidney masses are frequently discovered by chance. Many of these masses are benign. However, most patients still undergo surgery because doctors cannot confirm the diagnosis from imaging alone. Artificial intelligence (AI) refers to computer systems that perform tasks normally requiring human intelligence, including machine learning, in which algorithms learn patterns directly from data, and radiomics, in which quantitative features are extracted from medical images to support diagnosis. These tools offer new ways to improve how kidney masses are detected, characterized, and treated. This narrative review summarizes current evidence on AI applications across the renal mass pathway, covering automated detection, imaging-based characterization, pathological staging, prognosis prediction, and AI-assisted surgical planning, while also outlining current limitations and future research directions. A review of the English-language literature was performed using PubMed and MEDLINE, with studies published between 2018 and 2026 prioritized. AI shows strong performance across all stages of the renal mass pathway. Deep learning models accurately detect and segment renal masses on CT and MRI. Radiomics-based classifiers distinguish benign from malignant lesions and predict tumor subtype without biopsy. Multimodal AI models predict survival with high accuracy and outperform established clinical scoring systems. AI-assisted surgical planning tools support nephron-sparing surgery and predict postoperative kidney function. Wider clinical use requires better prospective validation, more diverse datasets, and improved model transparency.Keywords
This publication has 26 references indexed in Scilit:
- Artificial intelligence-based segmentation of small renal masses: a multi-center, multi-scanner, multi-sequence studyAbdominal Radiology, 2025
- Artificial intelligence-based multimodal prediction for nuclear grading status and prognosis of clear cell renal cell carcinoma: a multicenter cohort studyInternational Journal of Surgery, 2025
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 UpdateEuropean Urology, 2025
- Application of artificial intelligence model in pathological staging and prognosis of clear cell renal cell carcinomaDiscover Oncology, 2024
- Multimodal deep learning for personalized renal cell carcinoma prognosis: Integrating CT imaging and clinical dataComputer Methods and Programs in Biomedicine, 2023
- Novel Imaging Methods for Renal Mass Characterization: A Collaborative ReviewEuropean Urology, 2022
- Radiomics to better characterize small renal massesWorld Journal of Urology, 2021
- Automated segmentation of kidney and renal mass and automated detection of renal mass in CT urography using 3D U-Net-based deep convolutional neural networkEuropean Radiology, 2021
- Clinical applications of artificial intelligence in urologic oncologyCurrent Opinion in Urology, 2020
- Role of Active Surveillance for Localized Small Renal MassesEuropean Urology Oncology, 2018